iShares Biotechnology ETF Holdings
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 8023.29m in AUM and 248 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.
Last Updated: 5 days, 2 hours ago
Last reported holdings - iShares Biotechnology ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
GILD
|
Gilead Sciences Inc | $630.7 million |
|
AMGN
|
Amgen Inc | $611.1 million |
|
VRTX
|
Vertex Pharmaceuticals Inc | $605.9 million |
|
REGN
|
Regeneron Pharmaceuticals Inc | $587.1 million |
|
ALNY
|
Alnylam Pharmaceuticals Inc | $324.8 million |
|
INSM
|
Insmed Inc | $260.2 million |
|
ARGX
|
argenx SE ADR | $250.2 million |
|
BIIB
|
Biogen Inc | $200.4 million |
|
NTRA
|
Natera Inc | $196.5 million |
|
UTHR
|
United Therapeutics Corp | $187.5 million |
|
ONC
|
BeOne Medicines Ltd ADR | $157.5 million |
|
INCY
|
Incyte Corp | $138.4 million |
|
MRNA
|
Moderna Inc | $137.1 million |
|
ILMN
|
Illumina Inc | $136.8 million |
|
RVMD
|
Revolution Medicines Inc Ordinary Shares | $125.1 million |
|
ROIV
|
Roivant Sciences Ltd Ordinary Shares | $101.1 million |
|
NBIX
|
Neurocrine Biosciences Inc | $96.0 million |
|
GMAB
|
Genmab AS ADR | $95.6 million |
|
BBIO
|
BridgeBio Pharma Inc | $92.2 million |
|
IONS
|
Ionis Pharmaceuticals Inc | $90.7 million |
|
MEDP
|
Medpace Holdings Inc | $81.8 million |
|
MDGL
|
Madrigal Pharmaceuticals Inc | $81.5 million |
|
EXEL
|
Exelixis Inc | $80.4 million |
|
BMRN
|
BioMarin Pharmaceutical Inc | $79.9 million |
|
ASND
|
Ascendis Pharma AS ADR | $77.9 million |
|
PRAX
|
Praxis Precision Medicines Inc Ordinary Shares | $63.0 million |
|
CRL
|
Charles River Laboratories International Inc | $62.6 million |
|
ARWR
|
Arrowhead Pharmaceuticals Inc | $61.3 million |
|
PCVX
|
Vaxcyte Inc Ordinary Shares | $60.9 million |
|
TECH
|
Bio-Techne Corp | $60.3 million |
|
CYTK
|
Cytokinetics Inc | $59.2 million |
|
HALO
|
Halozyme Therapeutics Inc | $56.2 million |
|
AXSM
|
Axsome Therapeutics Inc | $54.0 million |
|
BNTX
|
BioNTech SE ADR | $53.5 million |
|
KRYS
|
Krystal Biotech Inc | $48.9 million |
|
PTGX
|
Protagonist Therapeutics Inc | $47.2 million |
|
RGEN
|
Repligen Corp | $46.9 million |
|
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | $43.5 million |
|
ALKS
|
Alkermes PLC | $43.1 million |
|
RYTM
|
Rhythm Pharmaceuticals Inc | $41.4 million |
|
ABVX
|
Abivax SA ADR | $41.0 million |
|
PTCT
|
PTC Therapeutics Inc | $40.5 million |
|
COGT
|
Cogent Biosciences Inc | $38.9 million |
|
ACLX
|
Arcellx Inc | $38.6 million |
|
TERN
|
Terns Pharmaceuticals Inc Ordinary Shares | $37.7 million |
|
NUVL
|
Nuvalent Inc Class A | $36.5 million |
|
MIRM
|
Mirum Pharmaceuticals Inc | $36.4 million |
|
TEM
|
Tempus AI Inc Class A common stock | $35.1 million |
|
XENE
|
Xenon Pharmaceuticals Inc | $34.9 million |
|
SRRK
|
Scholar Rock Holding Corp | $33.9 million |
|
FOLD
|
Amicus Therapeutics Inc | $33.4 million |
|
CRSP
|
CRISPR Therapeutics AG | $31.6 million |
|
APLS
|
Apellis Pharmaceuticals Inc | $31.4 million |
|
APGE
|
Apogee Therapeutics Inc | $29.8 million |
|
ACAD
|
ACADIA Pharmaceuticals Inc | $27.9 million |
|
BRKR
|
Bruker Corp | $27.7 million |
|
CRNX
|
Crinetics Pharmaceuticals Inc | $26.4 million |
|
CGON
|
CG Oncology Inc | $25.7 million |
|
SYRE
|
Spyre Therapeutics Inc | $24.2 million |
|
ERAS
|
Erasca Inc | $22.4 million |
|
TARS
|
Tarsus Pharmaceuticals Inc Ordinary Shares | $20.9 million |
|
TWST
|
Twist Bioscience Corp | $20.8 million |
|
CNTA
|
Centessa Pharmaceuticals PLC ADR | $20.7 million |
|
IDYA
|
IDEAYA Biosciences Inc | $20.6 million |
|
DNLI
|
Denali Therapeutics Inc | $20.3 million |
|
TVTX
|
Travere Therapeutics Inc Ordinary Shares | $20.1 million |
|
IBRX
|
ImmunityBio Inc Ordinary Shares | $19.8 million |
|
ARQT
|
Arcutis Biotherapeutics Inc Ordinary Shares | $19.2 million |
|
VCYT
|
Veracyte Inc | $18.7 million |
|
GPCR
|
Structure Therapeutics Inc ADR | $18.4 million |
|
EWTX
|
Edgewise Therapeutics Inc | $18.1 million |
|
TXG
|
10x Genomics Inc Ordinary Shares - Class A | $17.9 million |
|
LEGN
|
Legend Biotech Corp ADR | $17.8 million |
|
NAMS
|
NewAmsterdam Pharma Co NV | $17.3 million |
|
VERA
|
Vera Therapeutics Inc Class A | $16.9 million |
|
DYN
|
Dyne Therapeutics Inc Ordinary Shares | $16.7 million |
|
BEAM
|
Beam Therapeutics Inc | $16.5 million |
|
BCRX
|
BioCryst Pharmaceuticals Inc | $16.4 million |
|
KOD
|
Kodiak Sciences Inc | $16.1 million |
|
SRPT
|
Sarepta Therapeutics Inc | $16.1 million |
|
CAI
|
Caris Life Sciences Inc | $16.1 million |
|
IMVT
|
Immunovant Inc | $15.6 million |
|
ADMA
|
ADMA Biologics Inc | $15.5 million |
|
ADPT
|
Adaptive Biotechnologies Corp | $15.4 million |
|
SMMT
|
Summit Therapeutics Inc Ordinary Shares | $15.2 million |
|
ORKA
|
Oruka Therapeutics Inc | $15.0 million |
|
SNDX
|
Syndax Pharmaceuticals Inc | $14.8 million |
|
TNGX
|
Tango Therapeutics Inc | $14.4 million |
|
RARE
|
Ultragenyx Pharmaceutical Inc | $14.3 million |
|
IRON
|
Disc Medicine Inc Ordinary Shares | $13.8 million |
|
AGIO
|
Agios Pharmaceuticals Inc | $13.6 million |
|
GRAL
|
GRAIL Inc | $13.5 million |
|
DFTX
|
Definium Therapeutics Inc Ordinary Shares | $13.3 million |
|
ZYME
|
Zymeworks Inc Registered Shs | $13.3 million |
|
RCUS
|
Arcus Biosciences Inc | $13.3 million |
|
XTSLA
|
BlackRock Cash Funds Treasury SL Agency | $13.0 million |
|
AUPH
|
Aurinia Pharmaceuticals Inc | $13.0 million |
|
ELVN
|
Enliven Therapeutics Inc | $12.7 million |
|
DAWN
|
Day One Biopharmaceuticals Inc | $12.4 million |
|
VCEL
|
Vericel Corp | $12.0 million |
|
MLYS
|
Mineralys Therapeutics Inc | $11.9 million |
|
ALMS
|
Alumis Inc | $11.7 million |
|
ZLAB
|
Zai Lab Ltd ADR Repr 1 Shs | $11.6 million |
|
NRIX
|
Nurix Therapeutics Inc Ordinary Shares | $11.2 million |
|
STOK
|
Stoke Therapeutics Inc | $10.8 million |
|
NTLA
|
Intellia Therapeutics Inc | $10.7 million |
|
ANAB
|
AnaptysBio Inc | $10.7 million |
|
RXRX
|
Recursion Pharmaceuticals Inc Class A | $10.5 million |
|
TYRA
|
Tyra Biosciences Inc | $10.5 million |
|
RLAY
|
Relay Therapeutics Inc Ordinary Shares | $9.8 million |
|
AMLX
|
Amylyx Pharmaceuticals Inc | $9.6 million |
|
NVAX
|
Novavax Inc | $9.4 million |
|
IOVA
|
Iovance Biotherapeutics Inc | $9.2 million |
|
WVE
|
WAVE Life Sciences Ltd | $8.5 million |
|
IMCR
|
Immunocore Holdings PLC ADR | $8.4 million |
|
NVCR
|
NovoCure Ltd | $8.3 million |
|
GLPG
|
Galapagos NV ADR | $8.2 million |
|
GRFS
|
Grifols SA ADR | $7.8 million |
|
BHVN
|
Biohaven Ltd | $7.8 million |
|
NUVB
|
Nuvation Bio Inc Ordinary Shares - Class A | $7.7 million |
|
ATAI
|
AtaiBeckley Inc | $7.7 million |
|
TSHA
|
Taysha Gene Therapies Inc Ordinary Shares | $7.5 million |
|
OLMA
|
Olema Pharmaceuticals inc Ordinary Shares | $7.5 million |
|
SION
|
Sionna Therapeutics Inc | $7.4 million |
|
TRVI
|
Trevi Therapeutics Inc | $7.3 million |
|
VIR
|
Vir Biotechnology Inc | $7.2 million |
|
MESO
|
Mesoblast Ltd ADR | $7.1 million |
|
CRVS
|
Corvus Pharmaceuticals Inc | $6.9 million |
|
RAPP
|
Rapport Therapeutics Inc | $6.8 million |
|
QURE
|
uniQure NV | $6.8 million |
|
GERN
|
Geron Corp | $6.7 million |
|
FTRE
|
Fortrea Holdings Inc | $6.5 million |
|
XNCR
|
Xencor Inc | $6.2 million |
|
ABCL
|
AbCellera Biologics Inc Ordinary Shares | $6.1 million |
|
MBX
|
MBX Biosciences Inc | $6.0 million |
|
MAZE
|
Maze Therapeutics Inc | $5.9 million |
|
CDNA
|
CareDx Inc | $5.9 million |
|
TBPH
|
Theravance Biopharma Inc | $5.8 million |
|
GLUE
|
Monte Rosa Therapeutics Inc | $5.7 million |
|
KALV
|
KalVista Pharmaceuticals Inc | $5.6 million |
|
JANX
|
Janux Therapeutics Inc Ordinary Shares | $5.5 million |
|
BCAX
|
Bicara Therapeutics Inc | $5.5 million |
|
PHVS
|
Pharvaris NV Ordinary Shares | $5.4 million |
|
MNKD
|
MannKind Corp | $5.4 million |
|
ORIC
|
ORIC Pharmaceuticals Inc | $5.4 million |
|
CSTL
|
Castle Biosciences Inc | $5.3 million |
|
ANNX
|
Annexon Inc Ordinary Shares | $5.3 million |
|
URGN
|
UroGen Pharma Ltd | $5.2 million |
|
KURA
|
Kura Oncology Inc | $5.1 million |
|
INBX
|
Inhibrx Biosciences Inc | $5.1 million |
|
STVN
|
Stevanato Group SpA | $5.1 million |
|
ABUS
|
Arbutus Biopharma Corp | $5.0 million |
|
SEPN
|
Septerna Inc | $4.8 million |
|
ANRO
|
Alto Neuroscience Inc | $4.8 million |
|
GHRS
|
GH Research PLC | $4.7 million |
|
AVBP
|
ArriVent BioPharma Inc | $4.7 million |
|
CTMX
|
CytomX Therapeutics Inc | $4.7 million |
|
CGEM
|
Cullinan Therapeutics Inc | $4.6 million |
|
REPL
|
Replimune Group Inc | $4.4 million |
|
SLDB
|
Solid Biosciences Inc | $4.3 million |
|
PGEN
|
Precigen Inc | $4.3 million |
|
ARVN
|
Arvinas Inc | $4.3 million |
|
SVRA
|
Savara Inc | $4.2 million |
|
IRWD
|
Ironwood Pharmaceuticals Inc Class A | $4.1 million |
|
PHAT
|
Phathom Pharmaceuticals Inc Ordinary shares | $4.0 million |
|
ZVRA
|
Zevra Therapeutics Inc | $3.9 million |
|
CTKB
|
Cytek Biosciences Inc | $3.8 million |
|
MGTX
|
MeiraGTx Holdings PLC | $3.7 million |
|
SPRY
|
ARS Pharmaceuticals Inc | $3.7 million |
|
BIOA
|
Bioage Labs Inc | $3.7 million |
|
5CV.DE
|
CUREVAC NV | $3.6 million |
|
SANA
|
Sana Biotechnology Inc Ordinary Shares | $3.6 million |
|
RIGL
|
Rigel Pharmaceuticals Inc | $3.6 million |
|
ZBIO
|
Zenas BioPharma Inc | $3.4 million |
|
CMPS
|
Compass Pathways PLC ADR | $3.4 million |
|
FULC
|
Fulcrum Therapeutics Inc | $3.3 million |
|
OPK
|
OPKO Health Inc | $3.3 million |
|
FDMT
|
4D Molecular Therapeutics Inc Ordinary Shares | $3.2 million |
|
PRTA
|
Prothena Corp PLC | $3.1 million |
|
EBS
|
Emergent BioSolutions Inc | $3.1 million |
|
MYGN
|
Myriad Genetics Inc | $3.0 million |
|
PSNL
|
Personalis Inc | $2.9 million |
|
ABSI
|
Absci Corp | $2.9 million |
|
BBOT
|
BridgeBio Oncology Therapeutics Inc | $2.9 million |
|
CATX
|
Perspective Therapeutics Inc | $2.9 million |
|
ACRS
|
Aclaris Therapeutics Inc | $2.9 million |
|
ALT
|
Altimmune Inc | $2.9 million |
|
ALVO
|
Alvotech | $2.8 million |
|
VNDA
|
Vanda Pharmaceuticals Inc | $2.8 million |
|
ALLO
|
Allogene Therapeutics Inc | $2.8 million |
|
RGNX
|
Regenxbio Inc | $2.8 million |
|
RCKT
|
Rocket Pharmaceuticals Inc | $2.7 million |
|
PACB
|
Pacific Biosciences of California Inc | $2.7 million |
|
LXEO
|
Lexeo Therapeutics Inc | $2.6 million |
|
CTNM
|
Contineum Therapeutics Inc Class A Common Stock | $2.6 million |
|
ENTA
|
Enanta Pharmaceuticals Inc | $2.6 million |
|
LCTX
|
Lineage Cell Therapeutics Inc | $2.6 million |
|
LAB
|
Standard BioTools Inc | $2.5 million |
|
ADCT
|
ADC Therapeutics SA | $2.5 million |
|
DSGN
|
Design Therapeutics Inc | $2.5 million |
|
AVIR
|
Atea Pharmaceuticals Inc Ordinary Shares | $2.5 million |
|
PRME
|
Prime Medicine Inc | $2.5 million |
|
FLGT
|
Fulgent Genetics Inc | $2.4 million |
|
TECX
|
Tectonic Therapeutic Inc | $2.4 million |
|
AURA
|
Aura Biosciences Inc | $2.3 million |
|
KYTX
|
Kyverna Therapeutics Inc | $2.2 million |
|
MRVI
|
Maravai LifeSciences Holdings Inc Ordinary Shares - Class A | $2.2 million |
|
IMRX
|
Immuneering Corp Class A | $2.1 million |
|
AVXL
|
Anavex Life Sciences Corp | $2.1 million |
|
TRDA
|
Entrada Therapeutics Inc | $2.0 million |
|
CYBN
|
CYBIN INC | $2.0 million |
|
CADL
|
Candel Therapeutics Inc | $2.0 million |
|
DNA
|
Ginkgo Bioworks Holdings Inc | $1.9 million |
|
UPB
|
Upstream Bio Inc | $1.9 million |
|
NGNE
|
Neurogene Inc | $1.9 million |
|
LENZ
|
LENZ Therapeutics Inc | $1.9 million |
|
AUTL
|
Autolus Therapeutics PLC ADR | $1.8 million |
|
EDIT
|
Editas Medicine Inc | $1.8 million |
|
CABA
|
Cabaletta Bio Inc Ordinary Shares | $1.7 million |
|
LRMR
|
Larimar Therapeutics Inc | $1.7 million |
|
CCCC
|
C4 Therapeutics Inc Ordinary Shares | $1.6 million |
|
KROS
|
Keros Therapeutics Inc | $1.5 million |
|
ARCT
|
Arcturus Therapeutics Holdings Inc | $1.4 million |
|
OABI
|
OmniAb Inc | $1.4 million |
|
NBP
|
NovaBridge Biosciences ADR | $1.3 million |
|
VYGR
|
Voyager Therapeutics Inc | $1.3 million |
|
ACIU
|
AC Immune SA | $1.2 million |
|
BCYC
|
Bicycle Therapeutics PLC ADR | $1.1 million |
|
CRBU
|
Caribou Biosciences Inc Ordinary Shares | $1.1 million |
|
CDXS
|
Codexis Inc | $1.1 million |
|
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | $1.1 million |
|
CLLS
|
Cellectis SA ADR | $1.1 million |
|
FHTX
|
Foghorn Therapeutics Inc Ordinary Shares | $1.1 million |
|
QTRX
|
Quanterix Corp | $1.0 million |
|
SGMT
|
Sagimet Biosciences Inc Ordinary Shares - Series A | $990561 |
|
QSI
|
Quantum-Si Inc Ordinary Shares - Class A | $948984 |
|
SLN
|
Silence Therapeutics PLC ADR | $915257 |
|
TNYA
|
Tenaya Therapeutics Inc | $832608 |
|
NMRA
|
Neumora Therapeutics Inc | $823497 |
|
PEPG
|
PepGen Inc | $800520 |
|
HUMA
|
Humacyte Inc | $743001 |
|
BDTX
|
Black Diamond Therapeutics Inc Ordinary Shares | $686307 |
|
PYXS
|
Pyxis Oncology Inc | $504938 |
|
GOSS
|
Gossamer Bio Inc | $497243 |
|
MENS
|
Jyong Biotech Ltd | $444897 |
|
None
|
Akero Therapeutics Cvr | $340530 |
|
AARD
|
Aardvark Therapeutics Inc | $338802 |
|
IMMP
|
Immutep Ltd ADR | $284635 |
|
None
|
CASH COLLATERAL USD SGAFT | $249000 |
|
TKNO
|
Alpha Teknova Inc | $230628 |
|
None
|
Chinook Therapeutics Inc | $54564 |
|
None
|
Cartesian Therapeutics ([Wts/Rts]) 0% | $1949 |
|
None
|
Fusion Pharmaceuticals Inc Cvr | $1034 |
|
None
|
Cargo Therapeutics Inc | $2 |
|
None
|
Akouos Cvrs Prvt | $2 |
|
CRGX
|
CARGO THERAPEUTICS INC | $1 |
|
THRD
|
Third Harmonic Bio Inc | $1 |
|
None
|
RUSSELL 2000 EMINI CME JUN 26 | $0 |
|
None
|
E-MINI HEALTH CARE SECTOR JUN 26 | $0 |
|
IXCH6
|
E-MINI HEALTH CARE SECTOR MAR 26 | $0 |
|
None
|
OMNIAB INC $12.50 VESTING Prvt | $0 |
|
None
|
OMNIAB INC $15.00 VESTING Prvt | $0 |
|
None
|
USD CASH | $-9.5 million |
Recent Changes - iShares Biotechnology ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2026-03-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-03-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-03-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-11 |
THRD
|
THIRD HARMONIC BIO INC | -134,478 |
| 2026-03-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-03-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-05 |
VTYX
|
Ventyx Biosciences Inc | -473,207 |
| 2026-03-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-03 |
RAPT
|
RAPT Therapeutics Inc Ordinary Shares | -133,793 |
| 2026-03-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-02 |
RNA
|
Atrium Therapeutics Inc | -101,552 |
| 2026-03-02 |
RNAGBP
|
Avidity Biosciences Inc Ordinary Shares | -1.0 million |
| 2026-02-27 |
RNA
|
ATRIUM THERAPEUTICS INC | 101,552 |
| 2026-02-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-02-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-10 |
DVAX
|
DYNAVAX TECHNOLOGIES CORP | -845,239 |
| 2026-02-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-02-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-29 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-29 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-29 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -698,378 |
| 2026-01-29 |
DFTX
|
DEFINIUM THERAPEUTICS INC | 700,502 |
| 2026-01-28 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 698,378 |
| 2026-01-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-28 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-28 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -698,378 |
| 2026-01-28 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-27 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-27 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 701,918 |
| 2026-01-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-27 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-27 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -703,334 |
| 2026-01-26 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 703,334 |
| 2026-01-26 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-26 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-26 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -699,794 |
| 2026-01-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-23 |
ATAI
|
AtaiBeckley Inc | 2.0 million |
| 2026-01-23 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | 699,794 |
| 2026-01-23 |
ATAI
|
ATAIBECKLEY INC | -2.0 million |
| 2026-01-23 |
MNMD
|
DEFINIUM THERAPEUTICS INC | -699,086 |
| 2026-01-22 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-22 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-22 |
ATXS
|
Astria Therapeutics Inc | -369,763 |
| 2026-01-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-22 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -701,210 |
| 2026-01-22 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 699,086 |
| 2026-01-21 |
ATAI
|
ATAIBECKLEY NV | -2.0 million |
| 2026-01-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-21 |
ATAI
|
AtaiBeckley Inc | 2.0 million |
| 2026-01-21 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | 701,210 |
| 2026-01-21 |
MNMD
|
DEFINIUM THERAPEUTICS INC | -699,794 |
| 2026-01-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-16 |
ATAI
|
ATAIBECKLEY NV | 2.0 million |
| 2026-01-16 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 707,582 |
| 2026-01-16 |
DFTX
|
Mind Medicine Inc Ordinary Shares | -707,582 |
| 2026-01-16 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-07 |
CVAC
|
CUREVAC NV | -953,194 |
| 2026-01-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-29 |
STRO
|
Sutro Biopharma Inc | -139 |
| 2025-12-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-24 |
ARTV
|
Artiva Biotherapeutics Inc | -14,185 |
| 2025-12-24 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -805 |
| 2025-12-24 |
FATE
|
Fate Therapeutics Inc | -22,037 |
| 2025-12-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-16 |
MRUS
|
Merus NV | -6,411 |
| 2025-12-10 |
AKRO
|
Akero Therapeutics Inc | -515,954 |
| 2025-12-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-12-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-11-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-11-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-11-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | 288,000 |
| 2025-11-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | -288,000 |
| 2025-11-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-03 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-29 |
ETNB
|
89BIO INC | -882,111 |
| 2025-10-28 |
TRML
|
TOURMALINE BIO INC | -100,019 |
| 2025-10-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-08 |
VRNA
|
VERONA PHARMA ADR PLC | -326,177 |
| 2025-10-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-03 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-09-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-09-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-09-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-09-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-09-19 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-09-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-09-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-09-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-09-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-09-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-08-28 |
LYEL
|
LYELL IMMUNOPHARMA INC | -35,561 |
| 2025-08-28 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,128 |
| 2025-08-28 |
MRSN
|
MERSANA THERAPEUTICS INC | -24,368 |
| 2025-08-28 |
ITOS
|
ITEOS THERAPEUTICS INC | -223,616 |
| 2025-08-28 |
LYEL
|
LYELL IMMUNOPHARMA INC | 35,209 |
| 2025-08-27 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,368 |
| 2025-08-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-08-27 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -35,869 |
| 2025-08-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |